Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Plant Allergenic Extract [EPC]
Echinacea, Unspecified is a non-standardized plant allergenic extract used primarily in the diagnosis and treatment of plant-based allergies. It belongs to a broad pharmacological category that may include adrenergic and ammonium-binding activities depending on the specific preparation.
Name
Echinacea, Unspecified
Raw Name
ECHINACEA, UNSPECIFIED
Category
Non-Standardized Plant Allergenic Extract [EPC]
Drug Count
165
Variant Count
233
Last Verified
February 17, 2026
About Echinacea, Unspecified
Echinacea, Unspecified is a non-standardized plant allergenic extract used primarily in the diagnosis and treatment of plant-based allergies. It belongs to a broad pharmacological category that may include adrenergic and ammonium-binding activities depending on the specific preparation.
Detailed information about Echinacea, Unspecified
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Echinacea, Unspecified.
Echinacea, Unspecified refers to preparations derived from the Echinacea plant genus where the specific species (such as Echinacea purpurea, Echinacea angustifolia, or Echinacea pallida) or the exact plant parts used are not strictly standardized. According to the FDA’s Established Pharmacologic Class (EPC) indexing, it is primarily categorized as a Non-Standardized Plant Allergenic Extract. This classification indicates its use in clinical allergy settings, specifically for skin testing or immunotherapy (allergy shots).
Beyond its role as an allergen, pharmacological data suggests that certain unspecified Echinacea preparations may exhibit complex activities, including Ammonium Ion Binding Activity and interactions with alpha- and beta-adrenergic receptors. While traditionally used in herbal medicine to support the immune system, the 'unspecified' designation in a clinical context often refers to its role in diagnostic allergenic panels. Healthcare providers use these extracts to identify hypersensitivity reactions in patients sensitive to the Asteraceae (Compositae) family of plants.
At the molecular level, Echinacea, Unspecified functions through several distinct pathways depending on its clinical application:
> Important: Only your healthcare provider can determine if Echinacea, Unspecified is right for your specific condition.
For diagnostic skin prick testing, a single drop of the extract (typically 1:10 or 1:20 w/v) is applied to the skin. For intradermal testing, a dose of 0.02 mL to 0.05 mL is injected into the upper layers of the skin.
Dosage is highly individualized. It typically begins with a 'build-up phase' starting at very low concentrations (e.g., 0.1 mL of a 1:100,000 dilution) and increases weekly until a maintenance dose is reached.
Echinacea, Unspecified extracts may be used in children for allergy testing under the strict supervision of a pediatric allergist. Dosing is generally similar to adult diagnostic dosing but requires careful monitoring for systemic reactions. Oral use in children under 12 is often discouraged by some international regulatory bodies (such as the EMA) due to the risk of sensitization.
No specific adjustments are usually required for diagnostic testing. For systemic immunotherapy, caution is advised if the patient has severely impaired renal clearance.
No specific dosage adjustments are documented for allergenic extracts in patients with liver disease.
Elderly patients may have reduced skin reactivity, which can lead to false-negative results in diagnostic testing. Healthcare providers may adjust the concentration of the extract accordingly.
If a scheduled immunotherapy injection is missed, contact your allergist. The next dose may need to be reduced to prevent an adverse reaction, depending on how much time has passed.
Signs of overdose (systemic reaction) include generalized hives, swelling of the throat, wheezing, and low blood pressure. Emergency treatment with epinephrine is required immediately.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.
> Warning: Stop taking Echinacea, Unspecified and call your doctor immediately if you experience any of these.
Prolonged use of allergenic extracts in immunotherapy is generally intended to induce tolerance. However, chronic use of oral Echinacea (unspecified) has been associated in rare cases with the development of autoimmune symptoms or hepatotoxicity, though data is inconclusive.
While Echinacea, Unspecified itself may not always carry a specific black box warning, most allergenic extracts carry a general warning regarding the risk of Severe Systemic Allergic Reactions. These products should only be administered by clinicians trained in managing anaphylaxis.
Report any unusual symptoms to your healthcare provider.
Echinacea, Unspecified is a potent biological substance. It should only be used for the indications specified by a licensed healthcare provider. Patients with a history of severe asthma may be at higher risk for complications during administration.
No specific FDA black box warning exists solely for 'Echinacea, Unspecified,' but it falls under the general safety mandates for Allergenic Extracts. These mandates require administration in settings where emergency resuscitative equipment and epinephrine are immediately available.
This medication generally does not affect the ability to drive, unless a systemic reaction (such as dizziness or fainting) occurs.
Alcohol should be avoided on the day of administration, as it can increase vasodilation and potentially worsen the severity of an allergic reaction.
If a patient experiences a severe systemic reaction, the use of the extract must be discontinued immediately and re-evaluated by an immunology specialist.
> Important: Discuss all your medical conditions with your healthcare provider before starting Echinacea, Unspecified.
There are no well-documented food interactions with the injectable extract. However, patients with allergies to sunflower seeds, ragweed, or daisies may experience cross-reactivity.
Echinacea, Unspecified will directly affect the results of Skin Allergy Tests. It may also interfere with certain assays for ammonium levels due to its binding activity.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Patients allergic to members of the Asteraceae/Compositae family (including ragweed, chrysanthemums, marigolds, and daisies) are at a significantly higher risk of reacting to Echinacea, Unspecified.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Echinacea, Unspecified.
Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Immunotherapy is generally not started during pregnancy, though maintenance doses may sometimes be continued if the benefit outweighs the risk. There is a risk of uterine contractions if a systemic reaction occurs.
It is unknown if the components of Echinacea, Unspecified pass into breast milk. Caution should be exercised, though systemic absorption from diagnostic testing is unlikely to affect a nursing infant.
Safety and effectiveness in children under the age of 5 have not been fully established for all forms of allergenic extracts. Use in children requires specialized pediatric allergy supervision.
Clinical studies have not identified significant differences in responses between elderly and younger patients, though reduced skin reactivity (turgor) may complicate the interpretation of skin tests.
No specific dose adjustments are provided for patients with renal impairment, but monitoring for systemic toxicity is advised in cases of end-stage renal disease.
Use with caution in patients with severe hepatic dysfunction, as the metabolism of certain botanical alkaloids may be impaired.
> Important: Special populations require individualized medical assessment.
Echinacea, Unspecified acts as a Non-Standardized Plant Allergenic Extract. It triggers an IgE-mediated response in sensitive individuals. Additionally, raw data indicates Ammonium Ion Binding Activity, which involves the chemical sequestration of NH4+ ions. Its classification as an alpha- and beta-adrenergic agonist suggests it may bind to G-protein coupled receptors (GPCRs), specifically α1, α2, β1, and β2 receptors, potentially modulating sympathetic nervous system output.
| Parameter | Value |
|---|---|
| Bioavailability | Low (Intradermal); Variable (Oral) |
| Protein Binding | Not well-characterized |
| Half-life | 2–4 hours (systemic components) |
| Tmax | 15–30 minutes (local) |
| Metabolism | Hepatic |
| Excretion | Renal |
Medications containing this ingredient
Common questions about Echinacea, Unspecified
Echinacea, Unspecified is primarily used as an allergenic extract for the diagnosis and treatment of allergies to the Echinacea plant. In a clinical setting, healthcare providers use it in skin prick tests to determine if a patient is hypersensitive to the Asteraceae family of plants. It may also be used in immunotherapy, where small, increasing doses are given to help the body build tolerance to the allergen. While it has traditional uses for immune support, its 'unspecified' clinical designation focuses on its role as a diagnostic and desensitizing agent. Always consult an allergist to understand its specific role in your treatment plan.
The most common side effects are local reactions at the site of the skin test or injection, including redness, itching, and a raised bump known as a wheal. These symptoms usually appear within minutes and resolve within a few hours without treatment. Some patients may also experience mild systemic symptoms like sneezing, nasal congestion, or a slight headache. Occasionally, a delayed local reaction may occur several hours later, causing swelling and tenderness. If you notice hives or have trouble breathing, seek emergency medical care immediately as these are signs of a serious reaction.
It is generally advised to avoid alcohol on the days you receive an injection of Echinacea, Unspecified allergenic extract. Alcohol can cause blood vessels to dilate (expand), which may increase the rate at which the allergen enters your bloodstream and potentially increase the risk or severity of an allergic reaction. Furthermore, alcohol can mask the early symptoms of a systemic reaction, making it harder for you or your doctor to identify a problem. You should discuss your alcohol consumption habits with your healthcare provider before starting any immunotherapy. Staying hydrated with water is a safer alternative on treatment days.
Echinacea, Unspecified is classified as FDA Pregnancy Category C, meaning there is limited data on its safety in pregnant women. Most allergists recommend against starting new immunotherapy or allergy testing during pregnancy due to the risk of anaphylaxis, which can cause oxygen deprivation to the fetus or induce uterine contractions. However, if a woman is already on a stable maintenance dose of immunotherapy, some doctors may choose to continue treatment at a reduced dose. Decisions regarding its use during pregnancy must be made on a case-by-case basis by your obstetrician and allergist. Always inform your doctor if you are pregnant or planning to become pregnant.
For diagnostic purposes, Echinacea, Unspecified works very quickly, with skin test results usually appearing within 15 to 20 minutes. For therapeutic purposes, such as allergy immunotherapy, the process is much slower and requires a 'build-up' phase that can last 3 to 6 months. Patients typically do not see a significant reduction in their allergy symptoms until they reach their maintenance dose. The full benefits of immunotherapy often take 12 months or more of consistent treatment to become apparent. Long-term treatment usually continues for 3 to 5 years to ensure lasting immunity.
If you are using Echinacea, Unspecified for allergy immunotherapy, stopping suddenly will not cause withdrawal symptoms, but it will likely result in the return of your allergy symptoms. Discontinuing treatment before the recommended 3-to-5-year course is finished often means the desensitization effect will not be permanent. If you miss several doses, your healthcare provider may need to restart your treatment at a lower concentration to ensure safety. You should never stop or change your injection schedule without consulting your allergist. If you experience a severe reaction, your doctor will be the one to decide if the medication should be stopped permanently.
If you miss a scheduled immunotherapy injection of Echinacea, Unspecified, you should contact your allergist's office as soon as possible to reschedule. Do not attempt to 'double up' on your next dose or take an extra dose at home. The safety of immunotherapy depends on a specific timing and dosage schedule; if too much time passes between doses, your sensitivity to the extract may increase. Depending on the length of the delay, your doctor may need to repeat your last dose or even reduce the dose for your next visit. Consistent attendance is key to the success and safety of the treatment.
There is currently no clinical evidence to suggest that Echinacea, Unspecified, whether used as an allergenic extract or an oral supplement, causes weight gain. Unlike certain medications like corticosteroids or some antidepressants, allergenic extracts do not interfere with metabolic rate or appetite regulation. Any changes in weight while taking this medication are likely due to other factors, such as lifestyle changes or other medications. If you experience sudden or unexplained weight gain, you should discuss it with your healthcare provider to identify the underlying cause. It is important to maintain a healthy diet and exercise routine during any long-term medical treatment.
Echinacea, Unspecified can interact with several types of medications, particularly those that affect the immune or cardiovascular systems. Beta-blockers and ACE inhibitors are of particular concern because they can make allergic reactions more severe or harder to treat. Immunosuppressants like prednisone may also reduce the effectiveness of the extract by dampening the body's immune response. You must provide your healthcare provider with a complete list of all prescription drugs, over-the-counter medicines, and herbal supplements you are currently using. This allows your doctor to screen for potential interactions and adjust your treatment plan for maximum safety.
Because Echinacea, Unspecified is a biological product (an allergenic extract), the concept of 'generic' versions works differently than it does for standard chemical drugs. Various manufacturers may produce their own versions of unspecified Echinacea extracts, but these are not always considered bioequivalent because the source material and extraction methods can vary. These products are often referred to as 'non-standardized extracts,' meaning the potency can differ between brands. Always use the specific brand or preparation prescribed by your allergist to ensure consistency in your treatment. If a pharmacy offers a different version, consult your doctor before switching.